Whole-body Vibration for Exercise and Vascular Health Improvement
(VIBE-Rx Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking direct vasoactive medications (like nitrates).
What data supports the effectiveness of the treatment Whole Body Vibration Training (WBVT)?
Research shows that whole-body vibration (WBV) can improve muscle strength, balance, and blood flow, and reduce arterial stiffness, which is beneficial for vascular health. It has been effective in various groups, including postmenopausal women with high blood pressure and patients with chronic obstructive pulmonary disease.12345
Is whole-body vibration training safe for humans?
How is whole-body vibration training different from other treatments for vascular health improvement?
What is the purpose of this trial?
The overall goals of this pilot investigation are to determine 1) the feasibility of conducting home based WBV studies, and 2) to determine if sub-acute home based WBV can improve a) exercise capacity, b) conduit- and micro- vascular function, and c) skeletal muscle function.
Eligibility Criteria
This trial is for men and women over 18 years of age from any racial background. It's not suitable for those under 18, pregnant individuals, people taking direct vasoactive medications like nitrates, or anyone with a clinical diagnosis of liver, heart, kidney disease or complications from diabetes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 12 weeks of home-based whole-body vibration training to assess improvements in exercise capacity, vascular function, and skeletal muscle function.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Sub Acute Whole Body Vibration Training
Sub Acute Whole Body Vibration Training is already approved in European Union, United States, China for the following indications:
- Rehabilitation for stroke patients
- Improvement of muscle strength and balance
- Treatment of osteoporosis
- Management of spasticity in cerebral palsy and multiple sclerosis
- Rehabilitation for stroke patients
- Improvement of muscle strength and balance
- Treatment of osteoporosis
- Management of spasticity in cerebral palsy and multiple sclerosis
- Rehabilitation for stroke patients
- Improvement of muscle strength and balance
- Treatment of osteoporosis
- Management of spasticity in cerebral palsy and multiple sclerosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Augusta University
Lead Sponsor